On This episode of Stock Movers:
- BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.
- French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains
- B&M's stock has fallen 56% in 2025, extending the previous year’s 34% drop, as the firm struggles to contend with a cocktail of rising competition, increasing wage costs and a pinch on the low-income households that have been key to its past success.

On This episode of Stock Movers: - BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion. - French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it&rsquo;s now worth more than $8 billion &mdash; and some analysts see the potential for even more gains - B&amp;M's stock has fallen 56% in 2025, extending the previous year&rsquo;s 34% drop, as the firm struggles to contend with a cocktail of rising competition, increasing wage costs and a pinch on the low-income households that have been key to its past success.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

BP Spin Off, Abivax's 1600% Gains, B&M's Woes

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/35e87da0-4b06-4474-bc50-b3bd00a8afca/transcript

Advertisement